Trial Outcomes & Findings for Cross-over Comparison of the V60 System to Other Bi-Level Noninvasive Ventilators (NCT NCT00817804)

NCT ID: NCT00817804

Last Updated: 2009-08-19

Results Overview

Comfort on visual analog scale 0 - 100, 0 is best

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

3 participants

Primary outcome timeframe

30 minutes

Results posted on

2009-08-19

Participant Flow

Hospitalized adult patients enrolled between Jan 17 and Mar 3, 2009.

Excluded if did not meet inclusion or did meet exclusion criteria.

Participant milestones

Participant milestones
Measure
V60 First
Experimental Study device (used as the experimental device) first in the cross-over study
Conventional First
Experimental Study device (used as the experimental device) second in the cross-over study
Overall Study
STARTED
1
2
Overall Study
COMPLETED
1
2
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Cross-over Comparison of the V60 System to Other Bi-Level Noninvasive Ventilators

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
V60 First
n=1 Participants
Experimental Study device (used as the experimental device) first in the cross-over study
Conventional First
n=2 Participants
Experimental Study device (used as the experimental device) second in the cross-over study
Total
n=3 Participants
Total of all reporting groups
Age, Categorical
<=18 years
1 Participants
n=5 Participants
2 Participants
n=7 Participants
3 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age Continuous
16.0 years
STANDARD_DEVIATION 0 • n=5 Participants
11.5 years
STANDARD_DEVIATION 4.9 • n=7 Participants
13.0 years
STANDARD_DEVIATION 4.4 • n=5 Participants
Sex: Female, Male
Female
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Sex: Female, Male
Male
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
Region of Enrollment
Canada
1 participants
n=5 Participants
2 participants
n=7 Participants
3 participants
n=5 Participants

PRIMARY outcome

Timeframe: 30 minutes

Population: Analysis was per protocol

Comfort on visual analog scale 0 - 100, 0 is best

Outcome measures

Outcome measures
Measure
V60 First
n=1 Participants
Experimental Study device (used as the experimental device) first in the cross-over study
Conventional First
n=2 Participants
Experimental Study device (used as the experimental device) second in the cross-over study
Breathing Comfort
V60
10 visual analog scale
Standard Error 0
40 visual analog scale
Standard Error 14.1
Breathing Comfort
Conventional
33.3 visual analog scale
Standard Error 0
45 visual analog scale
Standard Error 7.1

SECONDARY outcome

Timeframe: 30 minutes

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 30 minutes

Breathing rate in breaths per minute

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 30 minutes

Liters per minute that the patient breathes

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 30 minutes

Beats per minute that the patient's heart is beating

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 30 minutes

Systolic and diastolic blood pressure

Outcome measures

Outcome data not reported

Adverse Events

V60 First

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Conventional First

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Adam Seiver

Respironics California

Phone: 760-703-6993

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: LTE60